Effect of LY2216684 on the Pharmacokinetics and Pharmacodynamics of Lorazepam in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2011
At a glance
- Drugs Edivoxetine; Lorazepam
- Indications Major depressive disorder
- Focus Pharmacokinetics
- 11 Mar 2011 Actual end date (February 2011) added as reported by ClinicalTrials.gov.
- 11 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jan 2011 New trial record